Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Alignment Healthcare Chief Medical Officer Kim Hyong sold 18,404 shares of the company's common stock on March 18, 2026, in a transaction executed to satisfy tax withholding obligations tied to the vesting of restricted stock units. The sale, which was non-discretionary, fetched a weighted-average price of $17.84 per share for a total of $328,327. …
European Union leaders agreed clear deadlines for a broad set of reforms aimed at making the single market of 450 million consumers more effective and competitive versus foreign rivals. The summit conclusions require EU institutions and member states to deliver measures on cross-border services, banking competitiveness, emissions trading, professio…
SentinelOne CEO Tomer Weingarten sold 38,864 Class A shares on March 17, 2026, for about $562,350 under a Rule 10b5-1 plan. The cybersecurity firm reported fourth-quarter fiscal 2026 revenue in line with expectations and 22% year-over-year revenue growth, but it is still unprofitable and its shares have slipped 25% over the past year. Several analy…
On March 18, 2026, Silver Lake Technology Investors V, L.P. and affiliated entities sold a total of $3.97 million in Dell Technologies Inc. (DELL) Class C common stock across two execution prices. The sales were executed in several tranches at weighted-average prices of $154.17 and $154.78 per share. Dell’s shares have risen 62% over the prior year…
CytomX Therapeutics CEO Sean A. McCarthy sold 118,969 shares on March 17, 2026, at $6.423 per share for $764,137 to meet tax obligations tied to the vesting of restricted stock units. The transaction leaves him with just over 1.07 million shares directly and an additional indirect holding in a family trust. The move occurs as the company advances a…
A group of Silver Lake-related entities disposed of $11.3 million of Dell Technologies Inc Class C Common Stock on March 18, 2026, after converting Class B shares into Class C at a conversion price of $0. The sales occurred in a $150.32 to $152.90 per share range. Dell shares have since risen to $156.76, marking nearly a 62% gain over the past year…
A group of Silver Lake investment vehicles sold 74,782 shares of Dell Technologies Class C stock on March 18, 2026, realizing roughly $11.3 million at prices between $150.32 and $152.90. The same entities converted 136,931 Class B shares into Class C shares. Dell shares have since risen to $156.76, with the company cited as undervalued by an invest…
Silver Lake Group and affiliated investment vehicles sold approximately $3.9 million of Dell Technologies Inc. (NASDAQ: DELL) Class C Common Stock on March 18, 2026, across two price points. The filings show in-kind distributions and conversions tied to the transactions, while Dell continues to report strong AI infrastructure demand and declared a …
Alignment Healthcare Chief Information Officer Robert L. Scavo sold 11,285 shares on March 18, 2026 at a weighted-average price of $17.84, raising $201,324 to satisfy tax withholding tied to vested restricted stock units. The sale was non-discretionary. The company recently reported robust fourth-quarter growth and faces a 13.2 million share second…
Edward Smolyansky, who holds roughly 10% of Lifeway Foods, sold 14,353 shares on March 19, 2026, at a weighted average price of $17.77, generating $255,052 in proceeds. The trade occurred while the stock was trading near its 52-week low. Lifeway also reported fourth-quarter 2025 results that missed analyst expectations on both EPS and revenue, alth…
Ludmila Smolyansky sold 10,000 shares of Lifeway Foods Inc (NASDAQ:LWAY) on March 18, 2026, generating $187,399 from transactions executed between $18.42 and $19.34 per share. The sale arrives while the stock trades close to a 52-week low and after the company reported fourth-quarter 2025 results that fell short of analyst expectations on both EPS …
HHS chief counselor Chris Klomp said he is encouraged by the roster of candidates being considered to lead the Centers for Disease Control and Prevention. Jay Bhattacharya, director of the National Institutes of Health, was named acting CDC director last month amid a wider Health and Human Services reorganization. The agency has experienced budget …
Alignment Healthcare Chief Human Resources Officer Andreas P. Wagner sold a combined 23,602 shares of the company's common stock in two transactions on March 18 and 19, 2026, generating approximately $425,476 in proceeds. One sale covered tax withholding on vested restricted stock units and was non-discretionary; the other was executed under a pre-…
Marcia Belvin, Senior Vice President and Chief Scientific Officer of CytomX Therapeutics, sold 31,492 shares on March 17, 2026, in a transaction disclosed on a Form 4. The sale, executed at $6.423 per share to meet tax obligations from restricted stock unit vesting, generated $202,273. CytomX is also pursuing a $250 million public offering as it ad…
Silver Lake Technology Investors V, L.P. and affiliated vehicles disposed of roughly $36.7 million of Dell Technologies Inc. Class C Common Stock on March 17, 2026, at prices between $153.14 and $155.00 per share. Dell’s shares have since traded up to $156.76, with InvestingPro data showing a 61.74% gain over the past year and a 25.08% return year-…
Christopher Ogden, chief financial officer of CytomX Therapeutics (CTMX), sold 19,323 shares on March 17, 2026, at $6.423 per share to cover tax liabilities tied to vesting restricted stock units. The transaction totaled $124,111 and followed by holdings of 296,948 shares, including 173,082 RSUs. Separately, CytomX has priced a public offering of 4…
Silver Lake Partners IV and affiliated investment vehicles sold 235,727 shares of Dell Technologies Class C common stock on March 17, 2026, for roughly $36.6 million. The transactions coincided with corporate conversions of Class B into Class C shares and follow a period of strong performance at Dell driven by AI server demand and related product e…
Robert Chatwani, President General Manager, Growth at DocuSign (DOCU), sold 17,492 shares on March 18, 2026, under a Rule 10b5-1 trading plan for total proceeds of about $803,042. DocuSign reported fiscal fourth-quarter 2026 EPS of $1.01 on revenue of $837 million, both above consensus. Multiple brokerages adjusted their price targets following the…
Aron Marquez, a director at Permian Resources Corp (NYSE: PR), reported the sale of 13,000 Class A shares in two transactions on March 17 and 18, 2026, totaling about $254,800. The trades were disclosed on a Form 4 and come while the stock sits near a 52-week high; the company also posted mixed fourth-quarter 2025 results with an EPS beat but a rev…
ContextLogic Holdings director Bobbili Raja acquired 29,000 shares of the company's common stock on March 17 for a total of $249,373, at per-share prices between $8.50 and $8.75. The shares now trade at $8.03. Raja’s disclosed ownership includes 350,000 shares held directly via an estate planning vehicle and an additional 18,269,534 shares held ind…
Castle Biosciences President and CEO Derek J. Maetzold sold a total of 19,300 shares of company common stock on March 17 and 18, 2026, in transactions filed on a Form 4. The trades, executed under a Rule 10b5-1 plan adopted in December 2025, generated $500,098 in proceeds. The company recently posted quarterly results that beat expectations on both…
Barry Ticho, chief medical officer at Stoke Therapeutics (STOK), sold 13,147 shares of common stock across March 17-19, 2026, generating about $413,019. The sales were conducted at prices between $31.2838 and $33.3754 per share and were reported on a Form 4 filing. Ticho also exercised options to purchase 1,365 shares at $2.19 on March 19. The tran…
Sarah Blake, SVP and Chief Accounting Officer at Venture Global, sold 200,000 Class A shares for $3.2 million on March 19, 2026, and concurrently exercised 200,000 options. The company reported a Q4 2025 EPS shortfall despite strong revenue growth and announced major project financing; analysts have adjusted price targets while an InvestingPro note…
Global Partners LP Chief Operating Officer Mark Romaine sold 2,223 common units of the partnership in two transactions on March 12 and March 13, 2026, totaling $105,751. The company reported mixed fourth-quarter 2025 results across its segments, and an analyst at Stifel raised the price target to $46 while keeping a Hold rating. InvestingPro data c…
Employees represented by United Steelworkers Local 7-1 began picketing at BP’s Whiting, Indiana, refinery after the company denied access to over 800 union members following a breakdown in contract negotiations. The dispute centers on proposed job cuts, wage reductions and changes to bargaining rights, while BP says it does not expect impacts to pr…
